Colleen McIlvennan
Concepts (291)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart-Assist Devices | 59 | 2024 | 567 | 11.550 |
Why?
| | Heart Failure | 84 | 2026 | 2323 | 8.940 |
Why?
| | Caregivers | 26 | 2024 | 1049 | 4.240 |
Why?
| | Decision Making | 15 | 2023 | 980 | 1.970 |
Why?
| | Terminal Care | 10 | 2022 | 282 | 1.940 |
Why?
| | Heart Transplantation | 9 | 2026 | 736 | 1.510 |
Why?
| | Quality of Life | 22 | 2024 | 3192 | 1.390 |
Why?
| | Palliative Care | 10 | 2024 | 1008 | 1.370 |
Why?
| | Ventricular Function, Left | 4 | 2020 | 541 | 1.040 |
Why?
| | Ventricular Dysfunction, Left | 5 | 2023 | 392 | 0.970 |
Why?
| | Choice Behavior | 2 | 2020 | 178 | 0.950 |
Why?
| | Delivery of Health Care | 4 | 2023 | 947 | 0.930 |
Why?
| | Health Knowledge, Attitudes, Practice | 7 | 2024 | 1416 | 0.880 |
Why?
| | Cardiology | 2 | 2019 | 353 | 0.880 |
Why?
| | Patient Care Team | 5 | 2024 | 689 | 0.870 |
Why?
| | Humans | 104 | 2026 | 144957 | 0.820 |
Why?
| | Thrombosis | 3 | 2021 | 393 | 0.800 |
Why?
| | Heart Injuries | 1 | 2023 | 42 | 0.750 |
Why?
| | Stress, Psychological | 3 | 2021 | 1153 | 0.740 |
Why?
| | Physician-Patient Relations | 4 | 2024 | 588 | 0.740 |
Why?
| | Patient Participation | 7 | 2025 | 433 | 0.730 |
Why?
| | Emotions | 6 | 2023 | 578 | 0.720 |
Why?
| | Registries | 7 | 2026 | 2385 | 0.710 |
Why?
| | Middle Aged | 42 | 2026 | 35928 | 0.670 |
Why?
| | Patients | 3 | 2023 | 182 | 0.660 |
Why?
| | Substance Abuse Detection | 2 | 2025 | 106 | 0.640 |
Why?
| | Prosthesis Implantation | 3 | 2019 | 153 | 0.640 |
Why?
| | Palliative Medicine | 2 | 2017 | 24 | 0.620 |
Why?
| | Patient Preference | 6 | 2024 | 225 | 0.620 |
Why?
| | Health Literacy | 3 | 2024 | 184 | 0.610 |
Why?
| | Delirium | 1 | 2021 | 104 | 0.610 |
Why?
| | Patient Readmission | 2 | 2015 | 759 | 0.580 |
Why?
| | Biomedical Research | 3 | 2020 | 710 | 0.570 |
Why?
| | Attitude to Death | 2 | 2016 | 73 | 0.560 |
Why?
| | Pneumonia, Viral | 2 | 2020 | 384 | 0.550 |
Why?
| | Aged | 33 | 2026 | 25947 | 0.550 |
Why?
| | Coronavirus Infections | 2 | 2020 | 378 | 0.550 |
Why?
| | Risk Assessment | 6 | 2020 | 3676 | 0.540 |
Why?
| | Betacoronavirus | 2 | 2020 | 286 | 0.540 |
Why?
| | Male | 50 | 2026 | 72406 | 0.530 |
Why?
| | Qualitative Research | 9 | 2024 | 1671 | 0.520 |
Why?
| | Patient Acceptance of Health Care | 3 | 2020 | 886 | 0.520 |
Why?
| | Decision Making, Computer-Assisted | 1 | 2017 | 18 | 0.510 |
Why?
| | Hospice Care | 3 | 2016 | 220 | 0.510 |
Why?
| | Female | 50 | 2026 | 78376 | 0.510 |
Why?
| | Surveys and Questionnaires | 9 | 2024 | 6053 | 0.500 |
Why?
| | Caliciviridae Infections | 1 | 2016 | 18 | 0.500 |
Why?
| | Hospital Records | 1 | 2016 | 10 | 0.490 |
Why?
| | Mexiletine | 1 | 2016 | 6 | 0.490 |
Why?
| | Amphetamine | 1 | 2016 | 38 | 0.480 |
Why?
| | Quality Improvement | 4 | 2021 | 1291 | 0.470 |
Why?
| | Hospitalization | 5 | 2024 | 2434 | 0.460 |
Why?
| | Cryosurgery | 1 | 2016 | 47 | 0.460 |
Why?
| | Physicians | 4 | 2020 | 940 | 0.460 |
Why?
| | Bereavement | 1 | 2016 | 62 | 0.460 |
Why?
| | Adaptation, Psychological | 9 | 2024 | 717 | 0.450 |
Why?
| | Myocardial Infarction | 1 | 2023 | 1209 | 0.450 |
Why?
| | Stroke Volume | 5 | 2026 | 651 | 0.440 |
Why?
| | Clinical Decision-Making | 2 | 2024 | 359 | 0.440 |
Why?
| | Transplant Recipients | 1 | 2016 | 180 | 0.430 |
Why?
| | Partial Thromboplastin Time | 1 | 2014 | 50 | 0.430 |
Why?
| | Patient-Centered Care | 4 | 2021 | 544 | 0.430 |
Why?
| | Heart Diseases | 2 | 2017 | 350 | 0.420 |
Why?
| | Tachycardia, Ventricular | 1 | 2016 | 181 | 0.420 |
Why?
| | Heart Ventricles | 4 | 2021 | 760 | 0.410 |
Why?
| | Adult | 29 | 2025 | 40506 | 0.400 |
Why?
| | Depression | 2 | 2021 | 1559 | 0.400 |
Why?
| | Treatment Outcome | 13 | 2024 | 11695 | 0.390 |
Why?
| | Advance Care Planning | 2 | 2017 | 243 | 0.390 |
Why?
| | Decision Support Techniques | 4 | 2020 | 456 | 0.390 |
Why?
| | Research Design | 1 | 2019 | 1137 | 0.380 |
Why?
| | United States | 19 | 2026 | 15988 | 0.380 |
Why?
| | Attitude to Health | 1 | 2016 | 436 | 0.370 |
Why?
| | Blood Coagulation | 1 | 2014 | 268 | 0.370 |
Why?
| | Drug Monitoring | 1 | 2016 | 395 | 0.370 |
Why?
| | Randomized Controlled Trials as Topic | 4 | 2025 | 1721 | 0.360 |
Why?
| | Pandemics | 2 | 2020 | 1695 | 0.360 |
Why?
| | Substance-Related Disorders | 2 | 2025 | 1094 | 0.360 |
Why?
| | Informed Consent | 1 | 2014 | 198 | 0.360 |
Why?
| | Socioeconomic Factors | 1 | 2016 | 1327 | 0.350 |
Why?
| | Interviews as Topic | 4 | 2024 | 901 | 0.350 |
Why?
| | Cardiovascular Diseases | 2 | 2024 | 2171 | 0.340 |
Why?
| | Anticoagulants | 2 | 2021 | 724 | 0.320 |
Why?
| | American Heart Association | 4 | 2024 | 350 | 0.320 |
Why?
| | Activities of Daily Living | 1 | 2014 | 441 | 0.320 |
Why?
| | Health Personnel | 2 | 2022 | 748 | 0.300 |
Why?
| | Program Development | 2 | 2023 | 370 | 0.280 |
Why?
| | Patient Reported Outcome Measures | 4 | 2024 | 489 | 0.260 |
Why?
| | Social Support | 3 | 2024 | 652 | 0.260 |
Why?
| | Patient Education as Topic | 3 | 2018 | 780 | 0.250 |
Why?
| | Risk Factors | 9 | 2021 | 10792 | 0.240 |
Why?
| | Withholding Treatment | 2 | 2016 | 81 | 0.230 |
Why?
| | Mental Health | 2 | 2023 | 792 | 0.230 |
Why?
| | Cost of Illness | 2 | 2020 | 321 | 0.220 |
Why?
| | Data Collection | 2 | 2019 | 635 | 0.220 |
Why?
| | Communication | 4 | 2024 | 967 | 0.220 |
Why?
| | Health Services Needs and Demand | 2 | 2024 | 280 | 0.210 |
Why?
| | Troponin | 1 | 2023 | 49 | 0.190 |
Why?
| | Cardiovascular Agents | 1 | 2024 | 164 | 0.190 |
Why?
| | Quality Assurance, Health Care | 1 | 2024 | 340 | 0.180 |
Why?
| | Prospective Studies | 5 | 2026 | 7997 | 0.170 |
Why?
| | Hospital Mortality | 2 | 2016 | 1031 | 0.170 |
Why?
| | Frailty | 1 | 2024 | 198 | 0.160 |
Why?
| | Trust | 1 | 2022 | 153 | 0.160 |
Why?
| | Guideline Adherence | 1 | 2025 | 589 | 0.160 |
Why?
| | Home Nursing | 1 | 2020 | 23 | 0.160 |
Why?
| | Survival Rate | 3 | 2024 | 2092 | 0.160 |
Why?
| | BK Virus | 1 | 2019 | 17 | 0.150 |
Why?
| | Thoracentesis | 1 | 2019 | 6 | 0.150 |
Why?
| | Self Report | 1 | 2024 | 873 | 0.150 |
Why?
| | Retrospective Studies | 12 | 2025 | 17101 | 0.150 |
Why?
| | Psychosocial Support Systems | 1 | 2019 | 16 | 0.150 |
Why?
| | Data Accuracy | 1 | 2019 | 65 | 0.150 |
Why?
| | Medicare | 2 | 2015 | 887 | 0.150 |
Why?
| | Aged, 80 and over | 5 | 2024 | 8279 | 0.140 |
Why?
| | Ethics Committees, Research | 1 | 2019 | 41 | 0.140 |
Why?
| | Family | 1 | 2023 | 679 | 0.140 |
Why?
| | Research Support as Topic | 1 | 2019 | 80 | 0.140 |
Why?
| | Home Infusion Therapy | 1 | 2018 | 4 | 0.140 |
Why?
| | Motion Pictures | 1 | 2019 | 21 | 0.140 |
Why?
| | Viremia | 1 | 2019 | 158 | 0.140 |
Why?
| | Device Removal | 1 | 2020 | 143 | 0.140 |
Why?
| | Biomarkers | 2 | 2023 | 4275 | 0.140 |
Why?
| | Chronic Disease | 3 | 2022 | 1813 | 0.140 |
Why?
| | Immunocompromised Host | 1 | 2019 | 201 | 0.140 |
Why?
| | Nurse Practitioners | 2 | 2019 | 140 | 0.140 |
Why?
| | Outpatients | 2 | 2023 | 443 | 0.140 |
Why?
| | Warfarin | 2 | 2021 | 170 | 0.140 |
Why?
| | Disease Progression | 3 | 2026 | 2852 | 0.130 |
Why?
| | Cardiotonic Agents | 1 | 2018 | 95 | 0.130 |
Why?
| | Kaplan-Meier Estimate | 2 | 2019 | 966 | 0.130 |
Why?
| | Renal Insufficiency | 1 | 2019 | 169 | 0.130 |
Why?
| | Prognosis | 6 | 2026 | 4293 | 0.130 |
Why?
| | Organ Transplantation | 1 | 2020 | 248 | 0.130 |
Why?
| | Spouses | 1 | 2018 | 108 | 0.130 |
Why?
| | Practice Guidelines as Topic | 1 | 2025 | 1563 | 0.130 |
Why?
| | Diphenoxylate | 1 | 2016 | 5 | 0.130 |
Why?
| | Research Personnel | 1 | 2019 | 186 | 0.130 |
Why?
| | Antidiarrheals | 1 | 2016 | 12 | 0.130 |
Why?
| | Loperamide | 1 | 2016 | 12 | 0.130 |
Why?
| | Atropine | 1 | 2016 | 37 | 0.130 |
Why?
| | Nursing Assessment | 1 | 2017 | 56 | 0.130 |
Why?
| | Periodicals as Topic | 1 | 2019 | 203 | 0.120 |
Why?
| | Pressure Ulcer | 1 | 2017 | 43 | 0.120 |
Why?
| | Terminally Ill | 1 | 2016 | 41 | 0.120 |
Why?
| | Patient Care Management | 1 | 2016 | 56 | 0.120 |
Why?
| | Voltage-Gated Sodium Channel Blockers | 1 | 2016 | 7 | 0.120 |
Why?
| | Continuity of Patient Care | 1 | 2019 | 292 | 0.120 |
Why?
| | Chromatography, Gas | 1 | 2016 | 32 | 0.120 |
Why?
| | Cause of Death | 1 | 2018 | 472 | 0.120 |
Why?
| | Follow-Up Studies | 6 | 2024 | 5417 | 0.120 |
Why?
| | Consumer Health Information | 1 | 2016 | 49 | 0.120 |
Why?
| | Gastrointestinal Agents | 1 | 2016 | 66 | 0.120 |
Why?
| | Mineralocorticoid Receptor Antagonists | 1 | 2016 | 68 | 0.120 |
Why?
| | Prosthesis Design | 2 | 2016 | 357 | 0.120 |
Why?
| | Health Policy | 2 | 2020 | 401 | 0.120 |
Why?
| | Truth Disclosure | 1 | 2016 | 50 | 0.120 |
Why?
| | Advanced Practice Nursing | 1 | 2016 | 45 | 0.120 |
Why?
| | Hospices | 1 | 2016 | 89 | 0.120 |
Why?
| | Canada | 1 | 2017 | 428 | 0.120 |
Why?
| | Mortality | 1 | 2018 | 376 | 0.110 |
Why?
| | Social Security | 1 | 2015 | 5 | 0.110 |
Why?
| | Medical Indigency | 1 | 2015 | 11 | 0.110 |
Why?
| | Sex Distribution | 1 | 2016 | 386 | 0.110 |
Why?
| | Diagnosis-Related Groups | 1 | 2015 | 35 | 0.110 |
Why?
| | Defibrillators, Implantable | 2 | 2016 | 382 | 0.110 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2016 | 222 | 0.110 |
Why?
| | Arrhythmias, Cardiac | 1 | 2018 | 361 | 0.110 |
Why?
| | Uncertainty | 1 | 2016 | 145 | 0.110 |
Why?
| | Drug Combinations | 1 | 2016 | 392 | 0.110 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2016 | 250 | 0.110 |
Why?
| | Reproducibility of Results | 3 | 2023 | 3415 | 0.110 |
Why?
| | Patient Care Planning | 1 | 2016 | 170 | 0.110 |
Why?
| | Referral and Consultation | 1 | 2021 | 853 | 0.110 |
Why?
| | Patient Selection | 1 | 2019 | 719 | 0.110 |
Why?
| | Multimedia | 1 | 2014 | 13 | 0.110 |
Why?
| | Factor X | 1 | 2014 | 25 | 0.110 |
Why?
| | Fee-for-Service Plans | 1 | 2015 | 98 | 0.110 |
Why?
| | Workload | 1 | 2016 | 170 | 0.110 |
Why?
| | Health Care Costs | 1 | 2018 | 427 | 0.110 |
Why?
| | Assisted Circulation | 1 | 2014 | 26 | 0.110 |
Why?
| | Atrial Fibrillation | 1 | 2021 | 550 | 0.110 |
Why?
| | Patient Protection and Affordable Care Act | 1 | 2015 | 103 | 0.110 |
Why?
| | Nurse's Role | 1 | 2016 | 170 | 0.110 |
Why?
| | Treatment Refusal | 1 | 2015 | 98 | 0.110 |
Why?
| | Family Relations | 1 | 2015 | 88 | 0.100 |
Why?
| | Central Nervous System Stimulants | 1 | 2016 | 185 | 0.100 |
Why?
| | Needs Assessment | 1 | 2016 | 404 | 0.100 |
Why?
| | Risk | 1 | 2016 | 911 | 0.100 |
Why?
| | Polymerase Chain Reaction | 1 | 2016 | 1054 | 0.100 |
Why?
| | Population Surveillance | 1 | 2017 | 485 | 0.100 |
Why?
| | Sex Factors | 2 | 2016 | 2114 | 0.100 |
Why?
| | Patient Discharge | 2 | 2022 | 983 | 0.100 |
Why?
| | Heparin | 1 | 2014 | 244 | 0.100 |
Why?
| | Cooperative Behavior | 1 | 2016 | 465 | 0.100 |
Why?
| | Length of Stay | 2 | 2017 | 1337 | 0.090 |
Why?
| | Mass Screening | 1 | 2021 | 1348 | 0.090 |
Why?
| | Cohort Studies | 1 | 2023 | 5965 | 0.090 |
Why?
| | Antibodies | 1 | 2014 | 403 | 0.090 |
Why?
| | Program Evaluation | 1 | 2016 | 949 | 0.090 |
Why?
| | Imaging, Three-Dimensional | 1 | 2016 | 583 | 0.090 |
Why?
| | Pain Management | 1 | 2016 | 405 | 0.090 |
Why?
| | Severity of Illness Index | 2 | 2017 | 2925 | 0.090 |
Why?
| | Immunosuppressive Agents | 1 | 2016 | 847 | 0.090 |
Why?
| | Acute Disease | 1 | 2014 | 1031 | 0.090 |
Why?
| | Practice Patterns, Physicians' | 1 | 2020 | 1358 | 0.080 |
Why?
| | Pilot Projects | 1 | 2016 | 1890 | 0.080 |
Why?
| | Health Behavior | 1 | 2016 | 786 | 0.080 |
Why?
| | Time Factors | 4 | 2024 | 7183 | 0.080 |
Why?
| | Motivation | 1 | 2015 | 610 | 0.080 |
Why?
| | Frail Elderly | 2 | 2024 | 134 | 0.080 |
Why?
| | Internet | 1 | 2014 | 700 | 0.080 |
Why?
| | Comorbidity | 3 | 2020 | 1660 | 0.070 |
Why?
| | Prevalence | 1 | 2016 | 2836 | 0.070 |
Why?
| | Attitude of Health Personnel | 1 | 2016 | 1186 | 0.070 |
Why?
| | Incidence | 1 | 2014 | 2883 | 0.070 |
Why?
| | Bayes Theorem | 2 | 2019 | 433 | 0.060 |
Why?
| | Colorado | 3 | 2025 | 4564 | 0.060 |
Why?
| | Academic Medical Centers | 2 | 2020 | 548 | 0.060 |
Why?
| | Disease Management | 2 | 2022 | 647 | 0.060 |
Why?
| | Tomography, X-Ray Computed | 1 | 2016 | 2738 | 0.060 |
Why?
| | Life Expectancy | 1 | 2026 | 72 | 0.060 |
Why?
| | Michigan | 1 | 2024 | 136 | 0.050 |
Why?
| | Benzodiazepines | 1 | 2025 | 168 | 0.050 |
Why?
| | Postoperative Complications | 3 | 2024 | 2920 | 0.050 |
Why?
| | Cross-Sectional Studies | 3 | 2024 | 5872 | 0.050 |
Why?
| | Shock, Cardiogenic | 1 | 2024 | 64 | 0.050 |
Why?
| | Congresses as Topic | 1 | 2025 | 221 | 0.050 |
Why?
| | Information Systems | 1 | 2023 | 57 | 0.050 |
Why?
| | Cannabinoids | 1 | 2025 | 182 | 0.050 |
Why?
| | Young Adult | 2 | 2016 | 14126 | 0.050 |
Why?
| | Proportional Hazards Models | 1 | 2026 | 1325 | 0.050 |
Why?
| | Comprehension | 1 | 2024 | 180 | 0.050 |
Why?
| | Consensus | 1 | 2024 | 489 | 0.040 |
Why?
| | Death | 1 | 2022 | 131 | 0.040 |
Why?
| | Patient Care | 1 | 2023 | 118 | 0.040 |
Why?
| | Self Care | 1 | 2024 | 389 | 0.040 |
Why?
| | Aftercare | 1 | 2022 | 224 | 0.040 |
Why?
| | Health Services Misuse | 1 | 2020 | 36 | 0.040 |
Why?
| | Role | 1 | 2020 | 29 | 0.040 |
Why?
| | Age Factors | 2 | 2019 | 3335 | 0.040 |
Why?
| | Patient Satisfaction | 1 | 2024 | 705 | 0.040 |
Why?
| | Pharmacogenomic Testing | 1 | 2020 | 62 | 0.040 |
Why?
| | Hospitals, Community | 1 | 2020 | 65 | 0.040 |
Why?
| | Thromboembolism | 1 | 2021 | 125 | 0.040 |
Why?
| | Social Responsibility | 1 | 2020 | 55 | 0.040 |
Why?
| | Income | 1 | 2020 | 202 | 0.040 |
Why?
| | Contraindications, Procedure | 1 | 2019 | 12 | 0.040 |
Why?
| | Contracts | 1 | 2019 | 11 | 0.040 |
Why?
| | Tertiary Care Centers | 1 | 2020 | 189 | 0.040 |
Why?
| | Visual Analog Scale | 1 | 2019 | 34 | 0.040 |
Why?
| | Pharmacogenetics | 1 | 2020 | 173 | 0.040 |
Why?
| | Self Efficacy | 1 | 2022 | 414 | 0.040 |
Why?
| | International Cooperation | 1 | 2019 | 198 | 0.040 |
Why?
| | Area Under Curve | 1 | 2019 | 331 | 0.040 |
Why?
| | Survival | 1 | 2018 | 38 | 0.030 |
Why?
| | Administration, Oral | 1 | 2021 | 848 | 0.030 |
Why?
| | Walk Test | 1 | 2018 | 80 | 0.030 |
Why?
| | Health Status | 1 | 2023 | 836 | 0.030 |
Why?
| | Random Allocation | 1 | 2018 | 363 | 0.030 |
Why?
| | Equipment Design | 1 | 2019 | 530 | 0.030 |
Why?
| | Viral Load | 1 | 2019 | 526 | 0.030 |
Why?
| | Infusions, Intravenous | 1 | 2018 | 423 | 0.030 |
Why?
| | ROC Curve | 1 | 2019 | 615 | 0.030 |
Why?
| | Intraoperative Care | 1 | 2017 | 62 | 0.030 |
Why?
| | Health Surveys | 1 | 2019 | 518 | 0.030 |
Why?
| | Adolescent | 1 | 2016 | 22453 | 0.030 |
Why?
| | Social Determinants of Health | 1 | 2020 | 301 | 0.030 |
Why?
| | Nurses | 1 | 2019 | 178 | 0.030 |
Why?
| | Hemorrhage | 1 | 2021 | 809 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 2019 | 1495 | 0.030 |
Why?
| | Postoperative Care | 1 | 2017 | 288 | 0.030 |
Why?
| | Life Change Events | 1 | 2016 | 147 | 0.030 |
Why?
| | Video Recording | 1 | 2016 | 213 | 0.030 |
Why?
| | Societies, Medical | 1 | 2019 | 887 | 0.030 |
Why?
| | Reference Values | 1 | 2016 | 798 | 0.030 |
Why?
| | Clinical Trials as Topic | 1 | 2019 | 1054 | 0.030 |
Why?
| | Antiviral Agents | 1 | 2019 | 768 | 0.030 |
Why?
| | Ambulatory Care | 1 | 2018 | 603 | 0.020 |
Why?
| | Survival Analysis | 1 | 2016 | 1385 | 0.020 |
Why?
| | Databases, Factual | 1 | 2019 | 1486 | 0.020 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2019 | 653 | 0.020 |
Why?
| | Stroke | 1 | 2021 | 1258 | 0.020 |
Why?
| | Quality of Health Care | 1 | 2016 | 693 | 0.020 |
Why?
| | Algorithms | 1 | 2019 | 1839 | 0.020 |
Why?
| | Telemedicine | 1 | 2020 | 948 | 0.020 |
Why?
| | Body Mass Index | 1 | 2019 | 2438 | 0.020 |
Why?
| | Anxiety | 1 | 2016 | 1110 | 0.020 |
Why?
| | Cognition | 1 | 2016 | 1269 | 0.020 |
Why?
| | Hypertension, Pulmonary | 1 | 2019 | 1980 | 0.020 |
Why?
| | Child | 1 | 2022 | 22657 | 0.010 |
Why?
|
|
McIlvennan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|